Capricor Therapeutics announced a headquarters milestone on July 14, 2026. Capricor Therapeutics entered into a lease for about 171,000 rentable square feet at 9625 Towne Centre Drive in San Diego to serve as its new headquarters, including expanded manufacturing cleanrooms.

What changed

The announcement establishes or expands the company’s headquarters presence in San Diego, CA. Capricor signed the lease with ARE-SD Region No. 39 Owner, LLC on July 9, 2026, with the term estimated to begin on the earlier of the date its lease contingency related to FDA approval is satisfied or waived, or December 31, 2026. The initial monthly base rent is $5.60 per rentable square foot, or approximately $958,000 per month, and either party may terminate the lease if Capricor does not receive FDA approval of Deramiocel for Duchenne muscular dystrophy by December 31, 2026.

New headquarters: 9625 Towne Centre Drive, San Diego, California
Reported footprint: Approximately 171,000 rentable square feet, including expanded manufacturing cleanrooms
Announcement date: July 14, 2026

Why the company chose this location

The filing does not state why this location was selected. It says the premises are to be used as Capricor’s new headquarters, including expanded manufacturing cleanrooms, a research and development laboratory, administrative offices and other related uses.

What the move signals

A headquarters opening or relocation can signal new hiring capacity, consolidation of operating teams, investment in a regional ecosystem, or a change in how a company serves customers and partners. For GTM teams, the useful next step is to watch for role openings, regional leadership appointments, vendor consolidation, and facilities-related initiatives connected to the move.

Source and methodology

This profile uses the company or property owner’s announcement as its primary source. Future opening dates and planned occupancy are presented as announced and may change.

Primary source: Capricor Therapeutics headquarters announcement.